Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma

PURPOSE: Recently a combination of paclitaxel and carboplatin (TC) (without an anthracycline) has begun to be used as an adjuvant or remission induction therapy, without any critical supportive evidence of its efficacy relative to a combination chemotherapy of taxane, platinum and anthracycline such...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fujiwara, Kazuko, Egawa-Takata, Tomomi, Ueda, Yutaka, Kimura, Toshihiro, Yoshino, Kiyoshi, Fujita, Masami, Miyatake, Takashi, Ohta, Yukinobu, Kamiura, Shoji, Enomoto, Takayuki, Kimura, Tadashi
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2011
Matèries:
Gynecologic Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325403/
https://ncbi.nlm.nih.gov/pubmed/22127553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00404-011-2154-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars